Un­der the gun af­ter Op­di­vo set­backs, Bris­tol-My­ers Squibb names a new chief sci­en­tist

Hot on the heels of a se­ries of painful set­backs for its mar­quee pro­gram for Op­di­vo, Bris­tol-My­ers Squibb $BMY is bring­ing in a new chief sci­en­tif­ic of­fi­cer. The bell­wether big biotech says that Fran­cis Cuss, 62, is “re­tir­ing” as of March 16, with Mass Gen­er­al vet Thomas Lynch tak­ing the top R&D job.

Lynch spent 23 years at Mass­a­chu­setts Gen­er­al Hos­pi­tal, serv­ing as chair­man and chief ex­ec­u­tive of­fi­cer of Mass­a­chu­setts Gen­er­al Physi­cians Or­ga­ni­za­tion and as a mem­ber of the MGH Board from 2015 to 2017. He was al­so a pro­fes­sor of in­ter­nal med­i­cine at the Yale School of Med­i­cine from 2009 to 2015 and is step­ping down from the BMS board to take the new job.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.